Institute for Behavioral Medicine

Smyrna, Georgia 30082

0 studies enrolling now · 15 studies all time

What they study most

Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Autism, Autism Spectrum Disorders, Autistic Disorder, Behavioral Symptoms, Fibromyalgia, Major Depressive Disorder, Schizophrenia

Studies at this site

• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) — Completed
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD) — Completed
• Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl — Completed
• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) — Stopped early
• Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years — Completed
• Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder — Completed
• A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome — Completed
• A Trial of CM-AT in Children With Autism- Open Label Extension Study — Completed
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD — Completed
• A Trial of CM-AT in Children With Autism — Completed
• Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders — Completed
• Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders — Stopped early
• Switching to Iloperidone From Other Antipsychotics in Schizophrenia — Completed
• Study of Fluoxetine in Autism — Completed
• Extended Management and Measurement of Autism — Stopped early